Publication
Neurokinin-1 receptor, a new modulator of lymphangiogenesis in obese-asthma phenotype
dc.contributor.author | Ramalho, Renata | |
dc.contributor.author | Almeida, Joana | |
dc.contributor.author | Fernandes, Rúben | |
dc.contributor.author | Costa, Raquel | |
dc.contributor.author | Pirraco, Ana | |
dc.contributor.author | Guardão, Luísa | |
dc.contributor.author | Delgado, Luís | |
dc.contributor.author | Moreira, André | |
dc.contributor.author | Soares, Raquel | |
dc.date.accessioned | 2015-12-01T15:16:40Z | |
dc.date.available | 2020-01-01T01:30:11Z | |
dc.date.issued | 2013 | |
dc.date.updated | 2013-07-25T20:47:35Z | |
dc.description.abstract | Aims Obesity and asthma are widely prevalent and associated disorders. Recent studies of our group revealed that Substance P (SP) is involved in pathophysiology of obese-asthma phenotype in mice through its selective NK1 receptor (NK1-R). Lymphangiogenesis is impaired in asthma and obesity, and SP activates contractile and inflammatory pathways in lymphatics. Our aim was to study whether NK1-R expression was involved in lymphangiogenesis on visceral (VAT) and subcutaneous (SAT) adipose tissues and in the lungs, in obese-allergen sensitized mice. Main methods Diet-induced obese and ovalbumin (OVA)-sensitized Balb/c mice were treated with a selective NK1-R antagonist (CJ 12,255, Pfizer Inc., USA) or placebo. Lymphatic structures (LYVE-1 +) and NK1-R expression were analyzed by immunohistochemistry. A semi-quantitative score methodology was used for NK1-R expression. Key findings Obesity and allergen-sensitization together increased the number of LYVE-1 + lymphatics in VAT and decreased it in SAT and lungs. NK1-R was mainly expressed on adipocyte membranes of VAT, blood vessel areas of SAT, and in lung epithelium. Obesity and allergen-sensitization combined increased the expression of NK1-R in VAT, SAT and lungs. NK1-R antagonist treatment reversed the effects observed in lymphangiogenesis in those tissues. Significance The obese-asthma phenotype in mice is accompanied by increased expression of NK1-R on adipose tissues and lung epithelium, reflecting that SP released during inflammation may act directly on these tissues. Blocking NK1-R affects lymphangiogenesis, implying a role of SP, with opposite physiological consequences in VAT, and in SAT and lungs. Our results provide a clue for a novel SP role in the obese-asthma phenotype. | pt_PT |
dc.identifier.doi | 10.1016/j.lfs.2013.06.010 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.22/7039 | |
dc.language.iso | eng | pt_PT |
dc.publisher | Elsevier | pt_PT |
dc.relation.publisherversion | http://www.sciencedirect.com/science/article/pii/S0024320513003378 | pt_PT |
dc.subject | Obesity | pt_PT |
dc.subject | Asthma | pt_PT |
dc.subject | Allergen-challenge | pt_PT |
dc.subject | NK1-R | pt_PT |
dc.subject | Substance P | pt_PT |
dc.subject | LYVE-1 | pt_PT |
dc.subject | Lymphangiogenesis | pt_PT |
dc.title | Neurokinin-1 receptor, a new modulator of lymphangiogenesis in obese-asthma phenotype | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 177 | pt_PT |
oaire.citation.startPage | 169 | pt_PT |
oaire.citation.title | Life Sciences | pt_PT |
oaire.citation.volume | 93 | pt_PT |
person.familyName | Fernandes | |
person.givenName | Rúben | |
person.identifier | 635792 | |
person.identifier.ciencia-id | 0D1F-4090-E82A | |
person.identifier.orcid | 0000-0001-8933-3984 | |
person.identifier.scopus-author-id | 57640135700 | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | 9e6c397c-62d8-4a40-8ec7-ad05ae0ebcc4 | |
relation.isAuthorOfPublication.latestForDiscovery | 9e6c397c-62d8-4a40-8ec7-ad05ae0ebcc4 |